CRIS

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Curis Inc

NASDAQ | CRIS

1.26

USD

$0.00

(

0.00%

)

At Close (As of Dec 1, 2025)

$17.71M

Market Cap

-

P/E Ratio

-3.3

EPS

$4.50

52 Week High

$1.02

52 Week Low

HEALTHCARE

Sector

CRIS Chart

Recent Chart
Price Action

CRIS Technicals

Tags:

CRIS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $11M
Cost Of Revenue $98K
Costof Goods And Services Sold $98K
Operating Income -$45M
Selling General And Administrative $17M
Research And Development $39M
Operating Expenses $55M
Investment Income Net -
Net Interest Income $1.2M
Interest Income $1.8M
Interest Expense $615K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $203K
Income Before Tax -$43M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$43M
Comprehensive Income Net Of Tax -
Ebit -$43M
Ebitda -$43M
Net Income -$43M

Revenue & Profitability

Earnings Performance

CRIS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $41M
Total Current Assets $26M
Cash And Cash Equivalents At Carrying Value $20M
Cash And Short Term Investments $20M
Inventory -
Current Net Receivables $3.3M
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill $9M
Investments -
Long Term Investments -
Short Term Investments $0
Other Current Assets $3M
Other Non Current Assets -
Total Liabilities $47M
Total Current Liabilities $19M
Current Accounts Payable $3M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $28M
Capital Lease Obligations $3M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $3M
Other Current Liabilities $15M
Other Non Current Liabilities $27M
Total Shareholder Equity -$6M
Treasury Stock -
Retained Earnings -$1.2B
Common Stock $85K
Common Stock Shares Outstanding $6.3M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$40M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $187K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment $29M
Cashflow From Financing $3.4M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$43M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $11M
Total Revenue $11M
Cost Of Revenue $98K
Costof Goods And Services Sold $98K
Operating Income -$45M
Selling General And Administrative $17M
Research And Development $39M
Operating Expenses $55M
Investment Income Net -
Net Interest Income $1.2M
Interest Income $1.8M
Interest Expense $615K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $203K
Income Before Tax -$43M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$43M
Comprehensive Income Net Of Tax -
Ebit -$43M
Ebitda -$43M
Net Income -$43M

CRIS News

CRIS Profile

Curis Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Curis, Inc. (Ticker: CRIS) is a biotechnology firm headquartered in Lexington, Massachusetts, specializing in the development of targeted therapies to meet urgent medical needs in oncology. The company employs innovative proprietary platforms to advance a pipeline of novel drug candidates designed for various cancer treatments, enhancing patient outcomes in this critical field. With a strong focus on research and development, Curis is strategically positioned to impact the future of cancer care significantly, aiming to drive advancements that address the complexities of cancer treatment.

LPTX
+368.57%
$2.05
DRCT
+3.90%
$0.11
PAVS
-92.84%
$0.07
BYND
+42.59%
$1.40
QTTB
+79.45%
$3.93
KALA
+46.98%
$1.42
NVDA
+1.39%
$179.47
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
IPG
-1.95%
$24.57
BITF
-6.87%
$3.24
TWOH
-15.38%
$0.00
FTEL
+38.78%
$1.17
ASST
-6.25%
$1.05
AXDX
-61.36%
$0.03
PLUG
-1.99%
$1.97
IVP
-0.40%
$0.12
AAL
-0.62%
$13.96
INTC
-1.44%
$39.97
ADAP
-15.14%
$0.05
CHR
+5.06%
$0.04
BURU
-8.17%
$0.22
BMNR
-11.76%
$29.22
NIO
-5.36%
$5.20
SOND
-23.45%
$0.12
NFE
+9.42%
$1.33
AHMA
+175.89%
$13.27
TSLA
-0.59%
$427.61
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ONDS
-3.48%
$7.62
MARA
-4.44%
$11.28
INHD
-23.22%
$0.17
F
-0.93%
$13.15
IRBT
+7.59%
$1.70
CLSK
-3.54%
$14.56
YGMZ
-4.40%
$0.10
SRM
+53.27%
$10.30
CNEY
-18.20%
$1.19
RPGL
+3.70%
$0.42
BMNU
+8.84%
$8.18
BTBT
-7.14%
$2.21
SNAP
-0.73%
$7.62
PFE
-1.69%
$25.30
WLGS
-5.57%
$0.04
RIVN
+4.65%
$17.64
CIFR
-3.28%
$19.68
MSTR
-6.97%
$164.81
MTSR
-0.35%
$70.50
ACHR
-3.45%
$7.52
SOFI
+4.31%
$29.72
CAN
-6.00%
$0.94
BBD
-1.75%
$3.63
DNN
-0.58%
$2.54
HOOD
-4.22%
$123.06
BTG
+3.35%
$4.62
AFMD
-34.94%
$0.18
RIG
+0.34%
$4.42
AMD
+1.06%
$219.84
GOOGL
-1.21%
$316.27
WULF
-2.38%
$15.14
PRPH
-5.55%
$0.19
GRAB
-2.85%
$5.29
EXK
-3.27%
$9.60
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AG
+3.15%
$15.71
PLTD
+0.21%
$7.05
GRYP
-10.38%
$1.38
HL
+1.67%
$17.10
NCT
-28.27%
$0.55
MODV
-25.22%
$0.43
APLD
+4.39%
$28.29
RUBI
-11.59%
$0.14
HBAN
+0.85%
$16.44
CPNG
-4.50%
$26.89
PLTR
+1.61%
$168.45
IREN
+1.05%
$48.31
CRWV
+3.69%
$75.82
RGTI
-5.69%
$24.11
ITUB
-1.21%
$7.70
VALE
+0.55%
$12.68
WBD
-0.61%
$23.85
T
-1.51%
$25.62
VHAI
-25.00%
$0.00
GPUS
-9.00%
$0.27
DVLT
-5.90%
$1.91
BTE
+0.18%
$3.22
TE
+8.97%
$4.48
IBRX
-1.05%
$2.33
NGD
-0.14%
$8.33
TSLG
-1.40%
$9.13
NFLX
+1.35%
$107.58
BAC
-0.18%
$53.55
GOOG
-1.20%
$316.27
SAND
-6.04%
$12.12
KVUE
+0.08%
$17.36
LPTX
+368.57%
$2.05
DRCT
+3.90%
$0.11
PAVS
-92.84%
$0.07
BYND
+42.59%
$1.40
QTTB
+79.45%
$3.93
KALA
+46.98%
$1.42
NVDA
+1.39%
$179.47
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
TLRY
-21.06%
$0.81
IPG
-1.95%
$24.57
BITF
-6.87%
$3.24
TWOH
-15.38%
$0.00
FTEL
+38.78%
$1.17
ASST
-6.25%
$1.05
AXDX
-61.36%
$0.03
PLUG
-1.99%
$1.97
IVP
-0.40%
$0.12
AAL
-0.62%
$13.96
INTC
-1.44%
$39.97
ADAP
-15.14%
$0.05
CHR
+5.06%
$0.04
BURU
-8.17%
$0.22
BMNR
-11.76%
$29.22
NIO
-5.36%
$5.20
SOND
-23.45%
$0.12
NFE
+9.42%
$1.33
AHMA
+175.89%
$13.27
TSLA
-0.59%
$427.61
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
ONDS
-3.48%
$7.62
MARA
-4.44%
$11.28
INHD
-23.22%
$0.17
F
-0.93%
$13.15
IRBT
+7.59%
$1.70
CLSK
-3.54%
$14.56
YGMZ
-4.40%
$0.10
SRM
+53.27%
$10.30
CNEY
-18.20%
$1.19
RPGL
+3.70%
$0.42
BMNU
+8.84%
$8.18
BTBT
-7.14%
$2.21
SNAP
-0.73%
$7.62
PFE
-1.69%
$25.30
WLGS
-5.57%
$0.04
RIVN
+4.65%
$17.64
CIFR
-3.28%
$19.68
MSTR
-6.97%
$164.81
MTSR
-0.35%
$70.50
ACHR
-3.45%
$7.52
SOFI
+4.31%
$29.72
CAN
-6.00%
$0.94
BBD
-1.75%
$3.63
DNN
-0.58%
$2.54
HOOD
-4.22%
$123.06
BTG
+3.35%
$4.62
AFMD
-34.94%
$0.18
RIG
+0.34%
$4.42
AMD
+1.06%
$219.84
GOOGL
-1.21%
$316.27
WULF
-2.38%
$15.14
PRPH
-5.55%
$0.19
GRAB
-2.85%
$5.29
EXK
-3.27%
$9.60
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
NWTN
-9.09%
$0.70
AG
+3.15%
$15.71
PLTD
+0.21%
$7.05
GRYP
-10.38%
$1.38
HL
+1.67%
$17.10
NCT
-28.27%
$0.55
MODV
-25.22%
$0.43
APLD
+4.39%
$28.29
RUBI
-11.59%
$0.14
HBAN
+0.85%
$16.44
CPNG
-4.50%
$26.89
PLTR
+1.61%
$168.45
IREN
+1.05%
$48.31
CRWV
+3.69%
$75.82
RGTI
-5.69%
$24.11
ITUB
-1.21%
$7.70
VALE
+0.55%
$12.68
WBD
-0.61%
$23.85
T
-1.51%
$25.62
VHAI
-25.00%
$0.00
GPUS
-9.00%
$0.27
DVLT
-5.90%
$1.91
BTE
+0.18%
$3.22
TE
+8.97%
$4.48
IBRX
-1.05%
$2.33
NGD
-0.14%
$8.33
TSLG
-1.40%
$9.13
NFLX
+1.35%
$107.58
BAC
-0.18%
$53.55
GOOG
-1.20%
$316.27
SAND
-6.04%
$12.12
KVUE
+0.08%
$17.36
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.